- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alebund Pharmaceuticals (Jiangsu) Ltd Class H (9637)
Alebund Pharmaceuticals (Jiangsu) Ltd Class H stock price live, this page displays HK 9637 stock exchange data. View the 9637 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alebund Pharmaceuticals (Jiangsu) Ltd Class H real time stock price chart below.
What Is the Alebund Pharmaceuticals (Jiangsu) Ltd Class H Stock Price Today?
The Alebund Pharmaceuticals (Jiangsu) Ltd Class H stock price today is 17.48.
What Is the Stock Symbol for Alebund Pharmaceuticals (Jiangsu) Ltd Class H?
The stock symbol for Alebund Pharmaceuticals (Jiangsu) Ltd Class H is "9637."
What Stock Exchange Does Alebund Pharmaceuticals (Jiangsu) Ltd Class H Trade On?
Alebund Pharmaceuticals (Jiangsu) Ltd Class H is listed and trades on the Hong Kong stock exchange.
Is Alebund Pharmaceuticals (Jiangsu) Ltd Class H a Good Stock to Buy?
Determining whether Alebund Pharmaceuticals (Jiangsu) Ltd Class H—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9637 quote. (ISIN: CNE100007QD0)
What Is the Alebund Pharmaceuticals (Jiangsu) Ltd Class H Stock Price Today?
The Alebund Pharmaceuticals (Jiangsu) Ltd Class H stock price today is 17.48.
What Is the Stock Symbol for Alebund Pharmaceuticals (Jiangsu) Ltd Class H?
The stock symbol for Alebund Pharmaceuticals (Jiangsu) Ltd Class H is "9637."
What Stock Exchange Does Alebund Pharmaceuticals (Jiangsu) Ltd Class H Trade On?
Alebund Pharmaceuticals (Jiangsu) Ltd Class H is listed and trades on the Hong Kong stock exchange.
Is Alebund Pharmaceuticals (Jiangsu) Ltd Class H a Good Stock to Buy?
Determining whether Alebund Pharmaceuticals (Jiangsu) Ltd Class H—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9637 quote. (ISIN: CNE100007QD0)
Hong Kong
Currency in HKD
17.48
-1.14(-6.12%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.89
19.63
52 wk Range
16.89
46.82
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.8919.63
52 wk Range
16.8946.82
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
9637 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
48.61
Upside
+178.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 48.61
(+178.11% Upside)
Earnings
Latest Release
Aug 26, 2026
EPS / Forecast
-0.57 / --
Revenue / Forecast
104.16M / --
Compare 9637 to Peers and Sector
Metrics to compare | 9637 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship9637PeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | 12.3x | −0.3x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 3.6x | 2.6x | 2.6x | |
Price / LTM Sales | 41.3x | 7.3x | 2.9x | |
Upside (Analyst Target) | 178.1% | 48.2% | 64.3% | |
Fair Value Upside | Unlock | 0.0% | 9.9% | Unlock |
Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Alebund Pharms H (9637) Stock Price Today?
The Alebund Pharms H stock price today is 17.48 HKD.
What Stock Exchange Does Alebund Pharms H Trade On?
Alebund Pharms H is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Alebund Pharms H?
The stock symbol for Alebund Pharms H is "9637."
What Is the Alebund Pharms H Market Cap?
As of today, Alebund Pharms H market cap is 5.94B HKD.
What Is Alebund Pharms H's Earnings Per Share (TTM)?
The Alebund Pharms H EPS (TTM) is -2.99.
From a Technical Analysis Perspective, Is 9637 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Alebund Pharms H Stock Split?
Alebund Pharms H has split 0 times.
How Many Employees Does Alebund Pharms H Have?
Alebund Pharms H has 169 employees.
What is the current trading status of Alebund Pharms H (9637)?
As of Oct 16, 2026, Alebund Pharms H (9637) is trading at a price of 17.48 HKD, with a previous close of 17.48 HKD. The stock has fluctuated within a day range of 16.89 HKD to 19.63 HKD, while its 52-week range spans from 16.89 HKD to 46.82 HKD.
What Is Alebund Pharms H (9637) Price Target According to Analysts?
The average 12-month price target for Alebund Pharms H is 48.61 HKD, with a high estimate of 52.17268888 HKD and a low estimate of 41.55678085 HKD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +178.11% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.